A new sensitive imaging biomarker for Parkinson disease?

被引：16
|
作者：
Lang, Anthony E. [1 ]
Mikulis, David [2 ]
机构：
[1] Univ Toronto, Div Neurol, Toronto, ON M5S 1A1, Canada
[2] Univ Toronto, Dept Radiol, Toronto, ON M5S 1A1, Canada
来源：
NEUROLOGY | 2009年 / 72卷 / 16期
关键词：
PROGRESSION; MIDBRAIN;
D O I：
10.1212/01.wnl.0000343512.36654.41
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1374 / 1375
页数：2
相关论文
共 50 条
  • [1] NEUROMELANIN-SENSITIVE RESONANCE IMAGING AS A PARKINSON'S DISEASE BIOMARKER
    Martin-Bastida, Antonio
    Schwarz, Stefan
    Xing, Yue
    Pietracupa, Sara
    Burn, David
    Silverdale, Monty
    Bajaj, Nin
    Grosset, Donald
    Auer, Dorothee
    Paola, Piccini
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [2] Neuromelanin-sensitive magnetic resonance imaging: Possibilities and promises as an imaging biomarker for Parkinson's disease
    Yan, Yayun
    Zhang, Mengchao
    Ren, Wenhua
    Zheng, Xiaoqi
    Chang, Ying
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2024, 59 (10) : 2616 - 2627
  • [3] A new biomarker for Parkinson's disease?
    Williams-Gray, Caroline H.
    MOVEMENT DISORDERS, 2016, 31 (01) : 42 - 42
  • [4] Substantia nigra area evaluated by neuromelanin-sensitive MRI as an imaging biomarker of disease progression in Parkinson's disease
    Fabbri, M.
    Reimao, S.
    Carbalho, M.
    Nunes, R.
    Abreu, D.
    Guedes, L.
    Bouca, R.
    Lobo, P.
    Godinho, C.
    Coelho, M.
    Goncalves, N.
    Rosa, M.
    Antonini, A.
    Ferreira, J.
    MOVEMENT DISORDERS, 2017, 32
  • [5] Substantia nigra area evaluated by neuromelanin-sensitive MRI as an imaging biomarker of disease progression in Parkinson's disease
    Fabbri, M.
    Reimao, S.
    Carvalho, M.
    Nunes, R.
    Guedes, L.
    Bouca, R.
    Lobo, A. P. S. P.
    Godinho, C.
    Coelho, M.
    Abreu, D.
    Goncalves, N.
    Rosa, M.
    Antonini, A.
    Ferreira, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 485 - 485
  • [6] Sensitive biomarker of Parkinson's disease linked to mutations in the glucocerebrosidase gene
    Pchelina, S.
    Nikolaev, M.
    Kopytova, A.
    Baydakova, G.
    Senkevich, K.
    Miliukhina, I.
    Usenko, T.
    Emelyanov, A.
    Zakharova, E.
    MOVEMENT DISORDERS, 2020, 35 : S210 - S210
  • [7] A minimally invasive biomarker for sensitive and accurate diagnosis of Parkinson's disease
    Wang, Zerui
    Gilliland, Tricia
    Kim, Hyun Jo
    Gerasimenko, Maria
    Sajewski, Kailey
    Camacho, Manuel V.
    Bebek, Gurkan
    Chen, Shu G.
    Gunzler, Steven A.
    Kong, Qingzhong
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2024, 12 (01):
  • [8] Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease
    Castellanos, Gabriel
    Fernandez-Seara, Maria A.
    Lorenzo-Betancor, Oswaldo
    Ortega-Cubero, Sara
    Puigvert, Marc
    Uranga, Javier
    Vidorreta, Marta
    Irigoyen, Jaione
    Lorenzo, Elena
    Munoz-Barrutia, Arrate
    Ortiz-de-Solorzano, Carlos
    Pastor, Pau
    Pastor, Maria A.
    MOVEMENT DISORDERS, 2015, 30 (07) : 945 - 952
  • [9] Imaging biomarker correlates with oxidative stress in Parkinson's disease
    Naduthota, Rajini M.
    Bharath, Rose D.
    Jhunjhunwala, Ketan
    Yadav, Ravi
    Saini, Jitender
    Christopher, Rita
    Pal, Pramod Kumar
    NEUROLOGY INDIA, 2017, 65 (02) : 263 - 268
  • [10] Is retinal optical coherence tomography an imaging biomarker for Parkinson disease?
    Ascaso, Francisco
    Jimenez, Beatriz
    Lopez del Val, Javier
    Pinilla Lozano, Isabel
    Perez-Garcia, Diana
    Ibanez-Alperte, Juan
    Cristobal, Jose
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
12345